Skip to main content
. Author manuscript; available in PMC: 2015 Nov 17.
Published in final edited form as: Horm Metab Res. 2014 Jul 10;47(4):280–283. doi: 10.1055/s-0034-1383652

Table 2.

Effect of Vitamin D Supplementation

Baseline Six Months Twelve Months
IL-6 (1.3-6.8 pg/ml) P = 0.67
Placebo 3.2 ± 2.0 2.9 ± 1.9 3.3 ± 2.0
Vitamin D 3.4 ± 2.0 3.3 ± 1.9 3.7 ± 2.4
TNF-α (0-3.8 pg/ml) P = 0.43
Placebo 1.1 ± 0.4 1.2 ± 0.4 0.9 ± 0.3
Vitamin D 1.2 ± 0.4 1.2 ± 0.5 1.1 ± 0.4
hsCRP (1.6-3.0 mg/l) P = 0.43
Placebo 5.6 ± 2.7 5.9 ± 2.9 5.6 ± 2.9
Vitamin D 5.6 ± 2.4 5.6 ± 2.5 5.8 ± 2.9
PAI-1 (320-8560 pg/ml) P = 0.14
Placebo 3700 ± 1800 3460 ± 1800 3230 ± 1740
Vitamin D 3010 ± 1800 3120 ± 1400 3030 ± 1470
IGF-1 (60-298 ng/ml) P = 0.88
Placebo 224 ± 120 ND 207 ± 130
Vitamin D 221 ± 96 ND 210 ± 120

Units and normal ranges are provided in parentheses; values are means ± SD; ND – not done